Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Presurgical Phase IIB Trial of Oral CDB-4124 vs. Placebo in Women With Stage I-II Primary Breast Cancer

NCT01800422 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT01800422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01800422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Presurgical Phase IIB Trial of Oral CDB-4124 vs. Placebo in Women With Stage I-II Primary Breast Cancer
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2013
Completion date
March 31, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia breast cancer, stage ib breast cancer, stage ii breast cancer